Is immunohistochemical epidermal growth factor receptor expression overestimated as a prognostic factor in head-neck squamous cell carcinoma?. A retrospective analysis based on a tissue microarray of 365 carcinomas

Human Pathology

Volumn 39, Issue 10, 2008, Pages 1527-1534

  Fischer, Claude ^a   Zlobec, Inti ^b   Stöckli, Edith ^a   Probst, Simone ^a   Storck, Claudio ^a   Tornillo, Luigi ^b   Lugli, Alessandro ^b   Wolfensberger, Markus ^a   Terracciano, Luigi ^b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

EGFR; Head and neck cancer; Immunohistochemistry; ROC curve analysis; Tissue microarray

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PLATINUM DERIVATIVE;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTEIN EXPRESSION; RADIATION DOSE; SQUAMOUS CELL CARCINOMA; TISSUE MICROARRAY;

CARCINOMA, SQUAMOUS CELL; DIAGNOSTIC ERRORS; DNA, NEOPLASM; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RETROSPECTIVE STUDIES; ROC CURVE; SURVIVAL RATE; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 50649113267     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2008.03.001     Document Type: Article

References (35)

1. Pignon J.P., Bourhis J., Domenge C., and Designe L. Chemotherapy added to loco-regional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 355 (2000) 949-955
2. Spector J.G., Sessions D.G., Haughey B.H., et al. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx. Laryngoscope 111 (2001) 1079-1087
3. Herbst R.S. Review of epidermal growth factor receptor biology. Int J Radiat Oncol Biol Phys 59 (2004) 21-26
4. Rubin G.J., Tweardy D.J., and Melhem M.F. Asynchronous modulation of transforming growth factor alpha and epidermal growth factor receptor protein expression in progression of premalignant lesions to head and neck squamous cell carcinoma. Clin Cancer Res 4 (1998) 13-20
5. Karamouzis M.V., Grandis J.R., and Argiris A. Therapies directed against epidermal growth factor receptor in aerodigestive carcinomas. JAMA 298 (2007) 70-82
6. Dassonville O., Formento J.L., Francoual M., et al. Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer. J Clin Oncol 11 (1993) 1873-1878
7. Eriksen J.G., Steiniche T., Askaa J., Alsner J., and Overgaard J. The prognostic value of epidermal growth factor receptor is related to tumor differentiation and the overall treatment time of radiotherapy in squamous cell carcinomas of the head and neck. Int J Radiat Oncol Biol Phys 58 (2004) 561-566
8. Gupta A.K., McKenna W.G., Weber C.N., et al. Local recurrence in head and neck cancer: relationship to radiation resistance and signal transduction. Clin Cancer Res 8 (2002) 885-892
9. Temam S., Kawaguchi H., El Naggar A.K., et al. Epidermal growth factor receptor copy number alterations correlate with poor clinical outcome in patients with head and neck squamous cancer. J Clin Oncol 25 (2007) 2164-2170
10. Aebersold D.M., Froehlich S.C., Jonczy M., et al. Expression of transforming growth factor-alpha, epidermal growth factor receptor and platelet-derived growth factors A and B in oropharyngeal cancers treated by curative radiation therapy. Radiother Oncol 63 (2002) 275-283
11. Bentzen S.M., Atasoy B.M., Daley F.M., et al. Epidermal growth factor receptor expression in pretreatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation therapy in a randomized controlled trial. J Clin Oncol 23 (2005) 5560-5567
12. Ang K.K., Berkey B.A., Tu X., et al. Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. Cancer Res 62 (2002) 7350-7356
13. Grandis J.R., Melhem M.F., Gooding W.E., et al. Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival. J Natl Cancer Inst 90 (1998) 824-832
14. Pivot X., Magne N., Guardiola E., Poissonnet G., et al. Prognostic impact of the epidermal growth factor receptor levels for patients with larynx and hypopharynx cancer. Oral Oncol 41 (2005) 320-327
15. Maurizi M., Almadori G., Ferrandina G., et al. Prognostic significance of epidermal growth factor receptor in laryngeal squamous cell carcinoma. Br J Cancer 74 (1996) 1253-1257
16. Smith B.D., Smith G.L., Carter D., et al. Molecular marker expression in oral and oropharyngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 127 (2001) 780-785
17. McShane L.M., Altman D.G., Sauerbrei W., Taube S.E., Gion M., and Clark G.M. Reporting recommendations for tumor marker prognostic studies (REMARK). J Natl Cancer Inst 97 (2005) 1180-1184
18. Vlachtsis K., Nikolaou A., Markou K., Fountzilas G., and Daniilidis I. Clinical and molecular prognostic factors in operable laryngeal cancer. Eur Arch Otorhinolaryngol 262 (2005) 890-898
19. Magne N., Pivot X., Bensadoun R.J., et al. The relationship of epidermal growth factor receptor levels to the prognosis of unresectable pharyngeal cancer patients treated by chemo-radiotherapy. Eur J Cancer 37 (2001) 2169-2177
20. Almadori G., Cadoni G., Galli J., et al. Epidermal growth factor receptor expression in primary laryngeal cancer: an independent prognostic factor of neck node relapse. Int J Cancer 84 (1999) 188-191
21. Putti T.C., To K.F., Hsu H.C., et al. Expression of epidermal growth factor receptor in head and neck cancers correlates with clinical progression: a multicentre immunohistochemical study in the Asia-Pacific region. Histopathology 41 (2002) 144-151
22. Miyaguchi M., Olofsson J., and Hellquist H.B. Expression of epidermal growth factor receptor in glottic carcinoma and its relation to recurrence after radiotherapy. Clin Otolaryngol Allied Sci 16 (1991) 466-469
23. Sauter G., Simon R., and Hillan K. Tissue microarrays in drug discovery. Nat Rev Drug Discov 2 (2003) 962-972
24. Zlobec I., Terracciano L., Jass J.R., and Lugli A. Value of staining intensity in the interpretation of immunohistochemistry for tumor markers in colorectal cancer. Virchows Arch 451 (2007) 763-769
25. Zlobec I., Steele R., Terracciano L., Jass J.R., and Lugli A. Selecting immunohistochemical cut-off scores for novel biomarkers of progression and survival in colorectal cancer. J Clin Pathol 60 (2007) 1112-1116
26. Efron B., and Tibshirani R. An Introduction to the Bootstrap (2004), Chapman & Hall/CRC, Boca Raton, FL
27. Bewick V., Cheek L., and Ball J. Statistics review 13: receiver operating characteristic curves. Crit Care 8 (2004) 508-512
28. Zlobec I., Vuong T., Hayashi S., et al. A simple and reproducible scoring system for EGFR in colorectal cancer: application to prognosis and prediction of response to preoperative brachytherapy. Br J Cancer 96 (2007) 793-800
29. Atkins D., Reiffen K.A., Tegtmeier C.L., Winther H., Bonato M.S., and Storkel S. Immunohistochemical detection of EGFR in paraffin-embedded tumor tissues: variation in staining intensity due to choice of fixative and storage time of tissue sections. J Histochem Cytochem 52 (2004) 893-901
30. Punglia R.S., D'Amico A.V., Catalona W.J., Roehl K.A., and Kuntz K.M. Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen. N Engl J Med 349 (2003) 335-342
31. Moch H., Schraml P., Bubendorf L., et al. High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma. Am J Pathol 154 (1999) 981-986
32. Torhorst J., Bucher C., Kononen J., et al. Tissue microarrays for rapid linking of molecular changes to clinical endpoints. Am J Pathol 159 (2001) 2249-2256
33. Nocito A., Bubendorf L., Tinner E.M., et al. Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade. J Pathol 194 (2001) 349-357
34. Simon R., Nocito A., Hubscher T., et al. Patterns of her-2/neu amplification and overexpression in primary and metastatic breast cancer. J Natl Cancer Inst 93 (2001) 1141-1146
35. Barlund M., Forozan F., Kononen J., et al. Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis. J Natl Cancer Inst 92 (2000) 1252-1259